Lee Financial Group Hawaii’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-2,280
Closed -$202K 37
2021
Q1
$202K Sell
2,280
-53,761
-96% -$5.33M 0.17% 28
2020
Q4
$5.23M Buy
56,041
+7,529
+16% +$600K 4.4% 7
2020
Q3
$3.09M Buy
48,512
+21,331
+78% +$1.25M 2.57% 16
2020
Q2
$1.42M Buy
+27,181
New +$1.17M 1.22% 20

Other funds holding ARKG

Lee Financial Group Hawaii's ARKG Position: Q2 2021 in Review

Lee Financial Group Hawaii sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2021, closing a stake of 2,280 shares — an estimated $202K sold.

Lee Financial Group Hawaii first reported a position in ARKG in Q2 2020 and held it in 4 quarters. The position peaked at $5.23M in Q4 2020. 514 funds tracked by Wall St. Rank hold ARKG as of Q2 2021.

  • Lee Financial Group Hawaii reported no remaining ARK Genomic Revolution ETF position as of Q2 2021 after selling out during the quarter.
  • Lee Financial Group Hawaii sold 2,280 ARK Genomic Revolution ETF shares in Q2 2021, an estimated $202K.
  • Lee Financial Group Hawaii first reported a position in ARK Genomic Revolution ETF in Q2 2020 and held it in 4 quarters.
  • Lee Financial Group Hawaii's ARK Genomic Revolution ETF position peaked at $5.23M in Q4 2020.
  • 514 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2021.

Based on Lee Financial Group Hawaii's 13F filing for Q2 2021, filed 9 Aug 2021.